Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
Chieffo A, Tanaka A, Giustino G, Briede I, Sawaya FJ, Daemen J, Kawamoto H, Meliga E, D'Ascenzo F, Cerrato E, Stefanini GG, Capodanno D, Mangiameli A, Templin C, Erglis A, Morice MC, Mehran R, Van Mieghem NM, Nakamura S, De Benedictis M, Pavani M, Varbella F, Pisaniello M, Sharma SK, Tamburino C, Tchetche D, Colombo A; DELTA 2 Investigators. Chieffo A, et al. Among authors: briede i. JACC Cardiovasc Interv. 2017 Dec 11;10(23):2401-2410. doi: 10.1016/j.jcin.2017.08.050. JACC Cardiovasc Interv. 2017. PMID: 29217002 Free article.
Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data.
Briede I, Narbute I, Kumsars I, Sondore D, Trushinskis K, Jegere S, Latkovskis G, Strenge K, Rudzitis A, Erglis A. Briede I, et al. Postepy Kardiol Interwencyjnej. 2018;14(2):144-148. doi: 10.5114/aic.2018.76405. Epub 2018 Jun 19. Postepy Kardiol Interwencyjnej. 2018. PMID: 30008766 Free PMC article.
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.
Tanaka A, Giustino G, Briede I, Sawaya FJ, Daemen J, Kawamoto H, Meliga E, D'Ascenzo F, Cerrato E, Stefanini GG, Capodanno D, Mangiameli A, Templin C, Erglis A, Morice MC, Mehran R, Van Mieghem NM, Nakamura S, De Benedictis M, Pavani M, Varbella F, Pisaniello M, Sharma SK, Tamburino C, Tchetche D, Colombo A, Chieffo A; DELTA 2 Investigators. Tanaka A, et al. Among authors: briede i. Int J Cardiol. 2019 Apr 1;280:30-37. doi: 10.1016/j.ijcard.2018.12.003. Epub 2018 Dec 15. Int J Cardiol. 2019. PMID: 30595357 Clinical Trial.
Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.
Trusinskis K, Lapsovs M, Paeglite S, Knoka E, Caunite L, Mazule M, Briede I, Jegere S, Kumsars I, Narbute I, Konrade I, Erglis A, Lejnieks A. Trusinskis K, et al. Among authors: briede i. J Clin Transl Res. 2021 Apr 16;7(2):270-276. eCollection 2021 Apr 22. J Clin Transl Res. 2021. PMID: 34104831 Free PMC article.
Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium.
Erglis A, Narbute I, Sondore D, Jegere S, Kumsars I, Dombrovskis A, Grikis K, Briede I, Dombrovska K, Trusinskis K, Grave A, Erglis M, Kalejs M, Stradins P, Strazdins U. Erglis A, et al. Among authors: briede i. J Interv Cardiol. 2022 Oct 31;2022:7934868. doi: 10.1155/2022/7934868. eCollection 2022. J Interv Cardiol. 2022. PMID: 36407753 Free PMC article.
21 results